Bml , Inc. TSE:4694
BML : Financial Results Presentation for Fiscal 2021
Source: MarketScreener
Financial Results
Presentation for Fiscal 2021
May 13, 2022
Kensuke Kondo,
President and
Representative Director
Overview of Fiscal 2021
Financial Results
2
10-Year Earnings History
Significant increase in tests related to COVID-19
(Millions of yen)
FY2021
3
Year-on-Year Comparison
(Millions of yen)
FY2020 | FY2021 | YoY | Change | |
Net sales | 138,571 | 186,067 | 47,495 | 34.3% |
Testing business | 132,911 | 179,751 | 46,840 | 35.2% |
Clinical testing business | 128,612 | 175,232 | 46,620 | 36.2% |
Other testing business | 4,299 | 4,519 | 220 | 5.1% |
Medical informatics business | 4,214 | 4,816 | 602 | 14.3% |
Other businesses | 1,445 | 1,498 | 52 | 3.7% |
Operating income | 19,936 | 48,889 | 28,953 | 145.2% |
Ordinary income | 20,803 | 51,077 | 30,273 | 145.5% |
Profit attributable to owners of | 13,711 | 33,741 | 20,029 | 146.1% |
parent | ||||
4
Breakdown of Changes in Sales by Business Segment
Net sales up 47,495m (34.3％) YoY
(Millions of yen)
+220 | +655 | |
+46,620 | Food hygiene | Medical |
business, etc. | informatics | |
business, | ||
Clinical | other businesses | |
testing | ||
business |
5
This is an excerpt of the original content. To continue reading it, access the original document here.